Avid Bioservices Inc (CDMO)

[pphmtoolong]

PPHMownsME, I am very bullish, because I rate this management team and stock from the decision point years ago when the company bet the ranch on Bavituximab.

From that point on there have false starts, slips and falls. However, the trajectory was generally heading up. IMO since the Fargo flap, which I can only consider bad luck, the Bavi science in the labs and clinics has been very good.

As we are now in Bavi Phase III in an indication that Bavi has already shown solid success, I am very optimistic regarding Peregrine's future.

Not only can we expect success in NSCLC, but we can also be positive on Bavi in breast cancer.

Add the dimension of Bavi with the new immunotherapies and I can see Peregrine shares reaching $5-10 by the end of 2016. As my cost average is around 1.30, that would make me very happy.

GLTA, Especially Bavi-arm Sunrise Patients,

Paul